The team was led by Alexander Gutmans (Partner, Transaction/M&A & Venture Capital) and Robert von Rosen (Partner, Transaction/M&A & Venture Capital) and included Ayesha Curmally (Partner, Notary Services), Jessica Aeschbach Flórez (Senior Associate, Transaction/M&A) and Karina Tschon (Associate Transaction/M&A).
Id est avocat acted as legal advisor to Techins in this transaction. The team included partner Mehmet Toral (pictured) and Marina Castelli-Joos.
VISCHER advises T3 Pharmaceuticals on all legal issues in connection with the transaction. The team consists of Christian Wyss (Partner, Corporate / M&A - pictured), Pauline Pfirter (Associate, Corporate / M&A), Ruben Masar (Associate, Corporate /
The team included Matthias Staehelin (pictured), Angelo Imperiale and Sebastian Flückiger (all Corporate) as well as Nadia Tarolli and Adrian Briner (both Tax).
The team was led by partner Daniel Hasler (Corporate | M&A - pictured) and comprises associates Mario Wälti, Marc Schamaun and junior associate Miriam Oelgarth (all Corporate | M&A).
The global software company Everbridge has acquired all of the issued shares in Techwan, a Swiss software company which specializes in public safety solutions and whose command and control systems are developed for and used
Sulzer has agreed to acquire the Swiss-German Haselmeier Group for EUR 100 million. Closing of the transaction is planned for the fourth quarter of 2020. Haselmeier is a leading provider of patented injection systems such as subcutaneous
Nacala Holdings – Luxembourg-based investment holding company – has agreed to acquire a 92.41% stake in EEII AG, the listed Switzerland-based private equity firm focused on investments in the electricity sector, from Gehold SA. The transaction is expected
Partners Group – Switzerland-based alternative asset management company and private equity firm that specializes in direct, secondary, and primary investments across private equity, private real estate, private infrastructure, private debt and liquid private markets strategies– has
Xlife Sciences – the Switzerland-based company engaged in researching, developing and commercialising therapeutics and medicines for the treatment of diseases – has acquired a 50% stake in palleos healthcare GmbH, a Germany-based clinical research organization that provides of
